1. "2014"
Formats
  1. Journal Article (2603)
  2. Meeting Abstract (1417)
  3. Book Section (235)
  4. Conference Paper (23)
  5. Book Whole (16)
  6. Review (3)
Groups
  1. Department of Medicine (1584)
  2. GSK Faculty (1082)
  3. Surgery (895)
  4. Solid Tumor Oncology Division (840)
  5. Center for Hematologic Malignancies (703)
  6. Sloan Kettering Institute Faculty (672)

More Groups

People
  1. Jedd Wolchok (71)
  2. Sergio Giralt (71)
  3. Ross Levine (69)
  4. Martin Tallman (62)
  5. Michael Berger (59)
  6. Mithat Gonen (55)

More People

Years
  1. 2014 (4297)
Publications
  1. Journal of Clinical Oncology (420)
  2. Blood (228)
  3. International Journal of Radiation Oncology, Biology, Physics (131)
  4. Cancer Research (104)
  5. Modern Pathology (89)
  6. Laboratory Investigation (82)

More Publications

Publishers
  1. Elsevier Inc. (495)
  2. American Society of Clinical Oncology (446)
  3. Springer (318)
  4. Elsevier Science, Inc. (246)
  5. Nature Publishing Group (242)
  6. American Society of Hematology (230)

More Publishers

Results (4297)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Nivolumab (anti-PD-1, BMS-936558, ONO-4538) in patients (pts) with advanced non-small-cell lung cancer (NSCLC): Survival and clinical activity by subgroup analysis
    Meeting Abstract

    Brahmer, J. R.; Horn, L.; Gandhi, L.; Spigel, D. R.; Antonia, S. J.; Rizvi, N. A.; Powderly, J. D.; Heist, R. S.; Carvajal, R. D.; Jackman, D. M.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Clinical activity and biomarkers of MEDI4736, an anti-PD-L1 antibody, in patients with NSCLC
    Meeting Abstract

    Brahmer, J. R.; Rizvi, N. A.; Lutzky, J.; Khleif, S.; Blake-Haskins, A.; Li, X.; Robbins, P. B.; Vasselli, J.; Ibrahim, R. A.; Antonia, S. J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The Memorial Sloan Kettering Cancer Center (MSKCC) experience of systemic therapy in mucosal melanoma
    Meeting Abstract

    Bitas, C.; Shoushtari, A. N.; Bluth, M. J.; Bhuchar, G.; Hester, R. H.; Romero, J.; Fitzpatrick, L.; Lefkowitz, R. A.; Panageas, K.; Schwartz, G. K.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Role of PET scan in predicting response to neoadjuvant chemotherapy and long-term outcomes for stage II lung cancer
    Meeting Abstract

    Bharat, A.; Guenthart, B.; Rusch, V. W.; Bains, M. S.; Rizk, N. P.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Somatic copy number abnormalities (SCNAs) and mutations in PI3K/AKT pathway as prognostic factors for overall survival (OS) in platinum-treated locally advanced or metastatic urothelial tumors
    Meeting Abstract

    Bellmunt, J.; Werner, L.; Leow, J. J.; Mullane, S. A.; Riester, M.; Van Hummelen, P.; Rosenberg, J. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Q-TWiST analysis of patients with metastatic renal cell carcinoma (mRCC) randomized to pazopanib (PAZ) or sunitinib (SUN)
    Meeting Abstract

    Beaumont, J. L.; Diaz, J.; Deen, K. C.; McCann, L.; Powles, T.; Hackshaw, M. D.; Motzer, R. J.; Cella, D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • A first-in-human study of pegylated recombinant human IL-10 (AM0010), daily administered for four months in selected advanced solid tumors
    Meeting Abstract

    Bauer, T. M.; Papadopoulos, K. P.; Autio, K. A.; Ott, P. A.; Whiteside, M.; Oft, M.; Infante, J. R.; Hod, F. S.; Wolchok, J. D.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • US Intergroup phase II trial (SWOG 1108) of alisertib, an investigational aurora A kinase (AAK) inhibitor, in patients with peripheral T-cell lymphoma (PTCL; NCT01466881)
    Meeting Abstract

    Barr, P. M.; Li, H. L.; Spier, C. M.; Mahadevan, D.; Friedberg, J. W.; LeBlanc, M. L.; Ul Haq, M.; Flowers, C.; Wagner-Johnston, N. D.; Cheson, B. D.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Phase Ib/II study of LEE011, everolimus, and exemestane in postmenopausal women with ER+/HER2-metastatic breast cancer
    Meeting Abstract

    Bardia, A.; Modi, S.; Gregor, M. C. M.; Kittaneh, M.; Marino, A. J.; Matano, A.; Bhansali, S.; Hewes, B.; Cortes, J.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • The ENABLE III randomized controlled trial of concurrent palliative oncology care
    Meeting Abstract

    Bakitas, M.; Tosteson, T.; Li, Z. G.; Lyons, K.; Hull, J.; Li, Z. Z.; Dionne-Odom, J. N.; Frost, J.; Hegel, M.; Azuero, A.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save